Drug
Opc 34712
Opc 34712: highest development phase Phase 1, developed by Otsuka. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Otsuka
Trials
| Drug | Phase | Indication |
|---|---|---|
| OPC-34712 NCT00805454 | Phase 1 | Schizophrenia |
Latest
No recent events.
Follow Opc 34712 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.